leisure time -WSS

leisure time

author：focus 2025-09-30 09:30:11 - browse：36

Beam Therapeutics said Thursday morning it would lay off 20% of its staff — or around 100 employees — and pause or reevaluate certain programs as it looks to cut costs.

It’s a notable setback for a gene-editing company that quickly raised over $1 billion in the few years after its co-founder, David Liu, described a new form of CRISPR, called base editing, that allowed researchers to change individual letters of DNA. The biotech hired rapidly, announced its intention to treat a broad range of diseases, and received clearance to start clinical trials in cancer and sickle cell.

Beam, however, has struggled to enroll patients in those trials. Meanwhile, the biotech stock market has stayed cold, including for gene-editing companies, whose technologies raise new regulatory, safety, and reimbursement questions. The pending approval of two gene therapies for sickle cell would also limit the market for Beam’s lead drug.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

explore

WSS

There should be a 'Moonshot' or 'Warp Speed' for rare diseases

Pfizer is about to make a big push in cancer. Will investors listen?

Congress extends some pandemic preparedness programs

Stop Congress from blocking public access to science

European officials brace for rough respiratory virus season

Medicare innovation center doesn’t save money, experts say

focus

leisure time

focus

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

The stability of $0 premiums in Medicare Advantage

New air purifier tech could be key to improving indoor air quality

Virtual repurposing can help discover new uses for existing drugs

Medicare details structure of new drug price negotiation program

Nobel honors Karikó and Weissman's enduring partnership

Tori Bowie and the unacceptable rates of Black maternal death

5 ways to address the shortage of health care workers

Drug repurposing or repositioning? The language matters

5 ways to address the shortage of health care workers

leisure time

CDC advisory group OKs chikungunya vaccine

WHO recommends second malaria vaccine

The Karikó problem: Lessons for funding basic research

'Vaccine

Ohio train derailment: Experts on toxic chemical risks

Readout Newsletter: GSK, Viking Therapeutics, mifepristone news

focus

explore

explore

Wikipedia